Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

Treatment of HCV genotype 1b (GT1b)-infected Japanese patients with paritaprevir (NS3/4A inhibitor boosted with ritonavir) and ombitasvir (NS5A inhibitor) in studies M12-536 and GIFT-I demonstrated high sustained virologic response (SVR) rates. The virologic failure rate was 3% (13/436) across the t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Antimicrob Agents Chemother
Main Authors: Krishnan, Preethi, Schnell, Gretja, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Zhang, Xinyan, Setze, Carolyn, Rodrigues, Lino, Burroughs, Margaret, Redman, Rebecca, Chayama, Kazuaki, Kumada, Hiromitsu, Collins, Christine, Pilot-Matias, Tami
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2016
主題:
Antiviral Agents
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750684/
https://ncbi.nlm.nih.gov/pubmed/26643326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02606-15
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍